![Michel Vounatsos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michel Vounatsos
Direttore/Membro del Consiglio presso
REVVITY, INC.
Patrimonio netto: 3 M $ in data 31/05/2026
Profilo
Michel Vounatsos è nel consiglio di amministrazione di PerkinElmer, Inc. (Stati Uniti), LInstitut de RYthmologie et Modlisation Cardiaque e n-Lorem Foundation e Chief Executive Officer & Director presso Biogen, Inc. Nella sua carriera passata ha occupato la posizione di Presidente-Primary Care & Customer Business Line presso Merck & Co., Inc. Il signor Vounatsos ha conseguito un MBA presso la cole des Hautes tudes Commerciales di Parigi.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
REVVITY, INC. 0,01% | 07/05/2026 | 13.977 ( 0,01% ) | 1 M $ | 31/05/2026 |
ZAI LAB LTD. 0,06% | 17/06/2026 | 727.870 ( 0,06% ) | 1 M $ | 31/05/2026 |
Posizioni attive di Michel Vounatsos
| Società | Posizione | Inizio |
|---|---|---|
| REVVITY, INC. | Direttore/Membro del Consiglio | 01/03/2020 |
| ZAI LAB LIMITED | Direttore/Membro del Consiglio | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Amministratore Delegato | 06/01/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Amministratore Delegato | - |
L’Institut de RYthmologie et Modélisation Cardiaque | Presidente | - |
n-Lorem Foundation
 n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Direttore/Membro del Consiglio | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michel Vounatsos
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Amministratore Delegato | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Formazione di Michel Vounatsos
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
 Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Health Technology |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
L’Institut de RYthmologie et Modélisation Cardiaque | |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Commercial Services |
